Immunome Aggregator, LP - Significant Ownership

Signature - Title
/s/ James P. Boylan - By: Enavate Sciences GP, LLC, its General Partner, By James P. Boylan, Manager
Location
Wilmington, DE
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Immunome Aggregator, LP.

Significant Ownership of Immunome Aggregator, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
IMNM IMMUNOME, INC. Common Stock, par value $0.0001 per share 6% $33.9M 4.77M Immunome Aggregator, LP Jan 31, 2025

Schedules 13D/G Reported by Immunome Aggregator, LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.